EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular Biomarkers With Potential Clinical Application in Testicular Cancer

João Lobo, Andres M Acosta, George J Netto

Modern Pathology · 2023-10 · 36 (10) · 100307

DOI: 10.1016/j.modpat.2023.100307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Modern Pathology, 2023-10. Verfasst von João Lobo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal;…. Hauptthemen laut MEDLINE: Testicular Neoplasms, Biomarkers, Tumor, Neoplasms, Germ Cell and Embryonal, Sex Cord-Gonadal Stromal Tumors. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 151 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testicular germ cell tumors (TGCTs) and sex cord-stromal tumors (SCSTs) are the most common testicular neoplasms. The morphologic spectrum of such tumors is wide, with several histologic subtypes within each group. Testicular tumors often represent a diagnostic challenge, requiring proper identification of their biologic potential for accurate risk stratification and selection of therapy. In the era of precision medicine, molecular biomarkers are increasingly assuming a critical role in the management of patients with cancer. Given the overall rarity of certain types of testicular neoplasms, progress in biomarker research has been relatively slow. However, in recent years, we have witnessed a multitude of important contributions, including both tissue-based and liquid biopsy biomarkers, stemming from important discoveries of tumor pathobiology, accurate histopathological analysis, multi-institutional studies, and genome-wide molecular analyses of specific tumor subtypes. In this review, we provide an overview of the progress in molecular biomarkers of TGCTs and SCSTs, focusing on those with greatest potential for clinical application. In TGCTs, developmental biology has been the key to understanding these tumors and identifying clinically useful biomarkers (from classical serum tumor markers to pluripotency factors and circulating microRNAs of the 371-373 cluster). For SCSTs, studies have focused on tissue biomarkers only, and genome-wide investigations have recently contributed to a better understanding of rare phenotypes and the aggressive biological behavior of some tumors within this nosologic category. Several new biomarkers are moving toward clinical implementation in this field. Therefore, the practicing pathologist should be aware of their strengths and limitations in order to utilize them properly and maximize their clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsBiomarkers, TumorNeoplasms, Germ Cell and EmbryonalSex Cord-Gonadal Stromal TumorsHumansMale

Stichwörter der Autor:innen

biomarkersgerm cell tumorsliquid biopsiesmolecular pathologysex cord-stromal tumorstesticular cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC…
  • Department of Pathology, Indiana University, Indianapolis, Indiana.
  • Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: gnetto@uabmc.edu.

Zitieren

APA

Lobo, J., Acosta, A. M., & Netto, G. J. (2023). Molecular Biomarkers With Potential Clinical Application in Testicular Cancer. Modern Pathology, 36(10), 100307. https://doi.org/10.1016/j.modpat.2023.100307

Vancouver

Lobo J, Acosta AM, Netto GJ. Molecular Biomarkers With Potential Clinical Application in Testicular Cancer. Modern Pathology. 2023;36(10):100307. doi:10.1016/j.modpat.2023.100307

BibTeX
@article{Lobo2023,
  author = {Lobo, João and Acosta, Andres M and Netto, George J},
  title = {Molecular Biomarkers With Potential Clinical Application in Testicular Cancer},
  journal = {Modern Pathology},
  year = {2023},
  volume = {36},
  number = {10},
  pages = {100307},
  doi = {10.1016/j.modpat.2023.100307}
}
Kostenlos starten →